MIRA INFORM REPORT

 

 

Report No. :

315575

Report Date :

11.04.2015

 

IDENTIFICATION DETAILS

 

Name :

SPECIFAR S.A.

 

 

Registered Office :

1, 28th Octovriou, Postal Code: 12351, Attica, Agia Varnava

 

 

Country :

Greece

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

01.01.1933

 

 

Com. Reg. No.:

106/03/Β/86/039

 

 

Legal Form :

Public Company

 

 

Line of Business :

·         Manufacture of pharmaceutical preparations

·         Wholesale of pharmaceutical goods

 

 

No. of Employees :

390

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Greece

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

GREECE - ECONOMIC OVERVIEW

 

Greece has a capitalist economy with a public sector accounting for about 40% of GDP and with per capita GDP about two-thirds that of the leading euro-zone economies. Tourism provides 18% of GDP. Immigrants make up nearly one-fifth of the work force, mainly in agricultural and unskilled jobs. Greece is a major beneficiary of EU aid, equal to about 3.3% of annual GDP. The Greek economy averaged growth of about 4% per year between 2003 and 2007, but the economy went into recession in 2009 as a result of the world financial crisis, tightening credit conditions, and Athens' failure to address a growing budget deficit. By 2013 the economy had contracted 26%, compared with the pre-crisis level of 2007. Greece met the EU's Growth and Stability Pact budget deficit criterion of no more than 3% of GDP in 2007-08, but violated it in 2009, with the deficit reaching 15% of GDP. Austerity measures have reduced the deficit to about 4% in 2013, including government debt payments. Deteriorating public finances, inaccurate and misreported statistics, and consistent underperformance on reforms prompted major credit rating agencies to downgrade Greece's international debt rating in late 2009, and led the country into a financial crisis. Under intense pressure from the EU and international market participants, the government adopted a medium-term austerity program that includes cutting government spending, decreasing tax evasion, overhauling the health-care and pension systems, and reforming the labor and product markets. Athens, however, faces long-term challenges to continue pushing through unpopular reforms in the face of widespread unrest from the country's powerful labor unions and the general public. In April 2010 a leading credit agency assigned Greek debt its lowest possible credit rating; in May 2010, the International Monetary Fund and Euro-Zone governments provided Greece emergency short- and medium-term loans worth $147 billion so that the country could make debt repayments to creditors. In exchange for the largest bailout ever assembled, the government announced combined spending cuts and tax increases totaling $40 billion over three years, on top of the tough austerity measures already taken. Greece, however, struggled to meet 2010 targets set by the EU and the IMF, especially after Eurostat - the EU's statistical office - revised upward Greece's deficit and debt numbers for 2009 and 2010. European leaders and the IMF agreed in October 2011 to provide Athens a second bailout package of $169 billion. The second deal however, called for holders of Greek government bonds to write down a significant portion of their holdings. As Greek banks held a significant portion of sovereign debt, the banking system was adversely affected by the write down and €41 billion of the second bailout package was set aside to ensure the banking system was adequately capitalized. In exchange for the second loan Greece promised to introduce an additional $7.8 billion in austerity measures during 2013-15. However, the massive austerity cuts have prolonged Greece's economic recession and depressed tax revenues. Throughout 2013, Greece's lenders called on Athens to step up efforts to increase tax collection, dismiss public servants, privatize public enterprises, and rein in health spending. In June 2013 Prime Minister Antonis SAMARAS's efforts to meet bailout conditions led to the departure of one party, the Democratic Left, from the governing coalition when his government made the controversial decision to shut down and restructure the state-owned television and radio company. Subsequent reluctance to institute further cuts and delays in meeting public sector reform targets prompted Greek lenders to withhold bailout fund disbursements until December 2013. However, investor confidence began to show signs of strengthening by the end of 2013 as leading macroeconomic indicators suggested the economy’s freefall had been arrested.

 

Source : CIA

 

 

Basic Information

 

Registered Name

SPECIFAR S.A.

Trade Name

ΣΠΕΣΙΦΑΡ Α.Ε.

Registered Address

1, 28th Octovriou, Postal Code: 12351, Attica, Agia Varnava, Greece

Telephone

+30 21 05401500, +30 21 05401600 / +30 21 05401552

Status

Registered and operational

Legal Type

SRL

 

VAT Number

094009565

 

Registration No

106/03/Β/86/039

Registration Date

29/12/1995

Start Date

01/01/1933

Years of Operation

82

End Date

01/01/2023

Last annual report

01/01/2011

Last return

08/04/2015

CR number

106/03/Β/86/039

Membership number

228201000

CINFO ID

3686142

 

Summary

 

Employees

Apr 2015

Total Number

390

Size class

250-999

 

 

Capital

 

Authorized Capital

28,660,487.00 EUR

Nominal No Of Shares

28,660,487

Nominal value

1.00 EUR

 

 

Corporate Structure

 

Directors

Position

ID

Nationality

Occupation

Age

Appointed

Other dir.

Mehta, Anish Kir.

Director

-

India

Executive Member Of The Board

-

-

No

Hirt - Vincent, Cheldon Jos.

Director

-

USA

Executive Member Of The Board

-

-

No

Oikonomou, Thomas Geo.

Director

-

Greece

Chairman & CEO

-

-

No

Rizos, Alexis Nik.

Director

-

Greece

Executive Vice Chairman

-

-

No

Vassilopoulos, Periklis Tit.

Director

047763393

Greece

Business Development Director

-

-

No

 

Secretary

Position

ID

Nationality

Occupation

Age

Appointed

Other dir.

No information available

 

Other Relations

Position

ID

Nationality

Appointed

 

Vourtsis, Petros

Marketing Director

 

Greece

 

 

 

Shareholders

ID/Reg. No.

Nationality

Shares

%

 

PAOMAR PLC

C263493

Cyprus

 

100

 

Other Directorship:

Name

Registration date

Reg. No

Status

Position

Update date

No information available

Other Shareholding:

Name

Registration date

Reg. No

Status

%

Update date

No information available

 

Operation

 

Activity Code

Description

 

[52.3] Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles

2442

Manufacture of pharmaceutical preparations

244

Manufacture of pharmaceuticals, medicinal chemicals and botanical products

5146

Wholesale of pharmaceutical goods

 

Line of business

SECTOR: Pharmaceuticals
NACE INDUSTRY
24.42 Manufacture of pharmaceutical preparations
51.46 Wholesale of pharmaceutical goods

The subject company is involved with production of medicines and medicated products. Exclusive imports and wholesale trade of medicines.

Company`s Products:

Medicines - Production, Import, Trade
OTC health - products Production, Import, Trade

 

Number of accounts

Market Share %

National

International

Local Sales

Local Purchases

Selling Terms

Sales Average Credit Period

Average Limit

Purchase Terms

Purchase Average Credit Period

Purchase Average Limit

0

1.54

0

0

0

0

-

N/A

0€

-

N/A

0

 

Sells to

Group Companies, General Public

 

Purchases

Raw materials, Products

 

Export to

Payment terms

Percentage

South Africa, Austria, Azerbaijan, Iraq, Lebanon, Malta, Romania, Russian Federation, Ukraine

-

N/A

 

 

Import from

Payment terms

Percentage

Belgium, Denmark, Finland, India, Malta

-

N/A

 

 

Banks

Swift code

HSBC BANK PLC
Agia Paraskevi, -, Greece

0710021

Comment

Bank number: 0710021

PIRAEUS BANK S.A.
Aigaleo, -, Greece

0172047

Comment

Bank number: 0172047

EFG EUROBANK ERGASIAS S.A.
Aigaleo, Center, Greece

0260017

Comment

Bank number: 0260017

NATIONAL BANK OF GREECE S.A.
Aigaleo, -, Greece

0110105

Comment

Bank Number: 0110105

Alpha Bank
Aigaleo, -, Greece

0140151

Comment

Bank Number: 0140151

 

Premises

Date Updated

Operates as: Headquarters

08/04/2015

1, 28th Octovriou, Postal Code: 183144, PO Box Postal Code: 183144, Attica, Agia Varnava, Greece

Operates as:

08/04/2015

Office

Leased

Antoni Tritsi, Postal Code: 55510, Thessaloniki, Pylaia, Greece

Operates as:

08/04/2015

Office

Leased

Komvos Pagni, Postal Code: 71410, Heraklion, Estavromenos, Greece

Operates as:

08/04/2015

Office

Leased

137, Australias, Postal Code: 174900, Patra, -, Greece

 

Affiliates and Subsidiaries

Country

Relation

Date Reg.

MILAN

France

Client

 

 

PHARMACISTS' SUPPLYING COOP. OF ATTIKA L.L.C.

Greece

Client

 

 

STADA

Germany

Client

 

 

BIOGARAW

France

Client

 

 

BETAFARM

Germany

Client

 

 

 

Agencies and Suppliers

Country

Relation

Date Reg.

No information available

 

CHARGES

 

No

Date Registered

Date Prepared

Type

Description

Amount

Secondary amount

Property

Unit

Beneficiary

No information available

 

Charges History

 

No

Date Registered

Date Prepared

Date End

Type

Description

Amount

Secondary amount

Property

Unit

Beneficiary

No information available

 

 

Negatives

 

According to our against the subject no negatives have been registered.

 

 

Financial information

 

Please note that the latest financial details were not available at the file of the company at the official companies' registry house; as the law provides for all companies. No financial details were available from other public sources.

 

 

Additional Information

 

CONCLUSION

Established in 1933, with name CHROMATOURGEIA G I METAXAS SA. In 1967, renamed SPESIFAR SA CHEMICAL-PHARMACEUTICAL HOLDINGS CONSTRUCTION and object of activity the sale of pharmaceutical products. In 1995, it acquired the name which is still active today: SPECIFAR SA Industrial chemicals & pharmaceuticals. By January 2011 the titre had secured over 600 marketing authorizations in Europe, South Africa, Canada, Middle East and Asia. Works with more than 200 companies in 36 countries, mainly in Europe. Company hasn`t published balance sheet for the fiscal year 2013.

The company was awarded with the following certifications:

ISO 9001:2008, TUV HELLAS (TUV NORD) S.A.
ISO 14001, TUV HELLAS (TUV NORD) S.A.

Please note that the information provided in this report was obtained from official, publicly available sources.

Contact Information

 

No information available

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.36

UK Pound

1

Rs.91.60

Euro

1

Rs.66.49

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

TPT

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.